In inflammatory bowel diseases (IBD), it is known that besides genetic and environmental
factors (eg diet, drugs, stress), the microbiota play an important role in the pathogenesis …

In recent years, novel insights have been made into the role of bacterial microflora in health
and disease. Commensal flora manipulation by probiotic bacteria has been investigated in …

In vitro and animals models have long been used to study human diseases and identify
novel therapeutic approaches that can be applied to combat these conditions. Ulcerative …

Bacteria are key initiating factors in the development of chronic intestinal inflammation that
characterizes the idiopathic inflammatory bowel diseases (IBDs), ulcerative colitis (UC) and …

Inflammatory bowel disease (IBD) has become a global public health problem. Although the
pathogenesis of the disease is unknown, a potential association between the gut microbiota …

Inflammatory bowel disease (IBD), which affects millions of people worldwide, includes two
separate diseases: Crohn's disease (CD) and ulcerative colitis (UC). Although the …

Probiotics are organisms which provide a desired and beneficial effect on human health.
With recent evidence implicating a disruption in the balance of the gastrointestinal …

Probiotics are defined as nonpathogenic living microorganisms, including some commensal
bacterial flora, which have beneficial effects on host health and disease prevention and/or …

The notion that the intestinal microbiota plays a key role for the development of intestinal
inflammation, initially based on a series of clinical observations both in human inflammatory …

The normal colonic microflora is intimately involved in the aetiology of inflammatory bowel
diseases (IBD) such as ulcerative colitis (UC) and Crohn's disease (CD). These conditions …